Cure My Disease

Don't miss your cure!

 Log in / Sign up

Two digital programs put to the test for everyday mental health struggles

NCT ID NCT07721870

Symptom relief Sponsor: Uppsala University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests two online programs for people with mild to moderate anxiety or depression who are not already in therapy. One program focuses on five daily behaviors linked to better mood, while the other uses a forgiveness process to address relationship issues. Participants choose their preferred program and complete daily mood check-ins over 10 weeks, with a follow-up after three months. The goal is to see which program people pick, how they use it, and whether it helps their mood.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
two online behavioral programs: one targeting five key daily behaviors (Things You Do) and one targeting forgiveness (REACH)
What this could lead to
If the programs appeal to patients and show mood improvements, they could offer a low-cost, accessible option for managing mild to moderate anxiety and depression in primary care.
What could go wrong
This is a very small exploratory study (14 participants) with no control group, so any benefits seen may not be due to the programs. Results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

14 people

The number who actually took part.

Started

Oct 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Mild to moderate self-reported depression (score of \<20 and \>4 on the PHQ-9) AND/OR * Mild to moderate anxiety symptoms (score of \>4 on the GAD-7) Exclusion Criteria: * Ongoing psychological treatment * Recently initiated medication for regulating mood or emotions (past 3 weeks) * Scores of \>19 or \<5 on the PHQ-9 * Scores of \<5 on the GAD-7 * Current suicidal thoughts or plans according to item 9 of the PHQ-9.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Depression

Contacts and locations

Locations

  • Halland Primary Care

    Varberg, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.